JP2022545815A5 - - Google Patents
Info
- Publication number
- JP2022545815A5 JP2022545815A5 JP2022513162A JP2022513162A JP2022545815A5 JP 2022545815 A5 JP2022545815 A5 JP 2022545815A5 JP 2022513162 A JP2022513162 A JP 2022513162A JP 2022513162 A JP2022513162 A JP 2022513162A JP 2022545815 A5 JP2022545815 A5 JP 2022545815A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/103041 | 2019-08-28 | ||
| CN2019103041 | 2019-08-28 | ||
| CNPCT/CN2019/125681 | 2019-12-16 | ||
| CN2019125681 | 2019-12-16 | ||
| PCT/CN2020/112181 WO2021037221A1 (en) | 2019-08-28 | 2020-08-28 | Nef-containing t cells and methods of producing thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022545815A JP2022545815A (ja) | 2022-10-31 |
| JPWO2021037221A5 JPWO2021037221A5 (https=) | 2023-10-06 |
| JP2022545815A5 true JP2022545815A5 (https=) | 2023-10-06 |
Family
ID=74683378
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513162A Pending JP2022545815A (ja) | 2019-08-28 | 2020-08-28 | Ｎｅｆ含有Ｔ細胞及びその産生方法 |
| JP2022513891A Pending JP2022547837A (ja) | 2019-08-28 | 2020-08-28 | 遺伝子操作されたｔ細胞及びその産生方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513891A Pending JP2022547837A (ja) | 2019-08-28 | 2020-08-28 | 遺伝子操作されたｔ細胞及びその産生方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20230085615A2 (https=) |
| EP (2) | EP4022044A4 (https=) |
| JP (2) | JP2022545815A (https=) |
| KR (2) | KR20230004898A (https=) |
| CN (3) | CN119709627A (https=) |
| AU (2) | AU2020336791A1 (https=) |
| CA (2) | CA3152936A1 (https=) |
| IL (1) | IL290946A (https=) |
| MX (1) | MX2022002325A (https=) |
| TW (2) | TW202122574A (https=) |
| WO (2) | WO2021037222A1 (https=) |
| ZA (1) | ZA202202127B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4282877A3 (en) | 2016-08-10 | 2024-02-21 | Legend Biotech Ireland Limited | Chimeric antigen receptors targeting bcma and methods of use thereof |
| AU2020232691B2 (en) | 2019-03-05 | 2023-06-29 | Nkarta, Inc. | CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
| US20240226294A9 (en) * | 2021-02-15 | 2024-07-11 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Customized chimeric antigen receptor polypeptides |
| TWI863006B (zh) * | 2021-10-18 | 2024-11-21 | 美商凱特製藥公司 | 用於嵌合抗原受體之信號傳導域 |
| CN120344250A (zh) * | 2022-10-25 | 2025-07-18 | 美商凯维那医疗公司 | 使用抗cd19 car-t细胞疗法治疗狼疮性肾炎的方法 |
| WO2024153211A1 (en) * | 2023-01-19 | 2024-07-25 | Nanjing Legend Biotech Co., Ltd. | Fusion polypeptides for targeted protein degradation and mehtods of use thereof |
| WO2024196969A2 (en) * | 2023-03-20 | 2024-09-26 | Memorial Sloan-Kettering Cancer Center | Cells and compositions for treating cancer |
| CN121419987A (zh) * | 2023-07-07 | 2026-01-27 | 南京传奇生物科技有限公司 | 蛋白质及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005070041A2 (en) * | 2004-01-09 | 2005-08-04 | Morehouse School Of Medicine | Modulating vaccine against hiv nef protein-induced lymphocyte depletion |
| WO2018132506A1 (en) * | 2017-01-10 | 2018-07-19 | The General Hospital Corporation | Chimeric antigen receptors based on alternative signal 1 domains |
| CN108395481B (zh) * | 2017-02-08 | 2021-02-05 | 西比曼生物科技（香港）有限公司 | 一种靶向cd20的car的构建及其工程化t细胞的活性鉴定 |
| BR112019021857A2 (pt) * | 2017-04-19 | 2020-06-02 | Allogene Therapeutics, Inc. | Métodos e composições de célula t aperfeiçoada |
| CN109306014B (zh) * | 2017-07-27 | 2022-04-12 | 上海细胞治疗研究院 | 一种靶向间皮素的嵌合抗原受体修饰t细胞及其用途 |
| WO2019126358A1 (en) * | 2017-12-22 | 2019-06-27 | Cell Design Labs, Inc. | Single- and multi-chain chimeric antigen receptors |
| SG11202006050XA (en) * | 2017-12-29 | 2020-07-29 | Memorial Sloan Kettering Cancer Center | Enhanced chimeric antigen receptors and uses thereof |
| US20210023170A1 (en) * | 2018-02-12 | 2021-01-28 | University Of Florida Research Foundation, Incorporated | Fviii chimeric antigen receptor tregs for tolerance induction in hemophilia a |
-
2020
- 2020-08-28 WO PCT/CN2020/112182 patent/WO2021037222A1/en not_active Ceased
- 2020-08-28 JP JP2022513162A patent/JP2022545815A/ja active Pending
- 2020-08-28 WO PCT/CN2020/112181 patent/WO2021037221A1/en not_active Ceased
- 2020-08-28 JP JP2022513891A patent/JP2022547837A/ja active Pending
- 2020-08-28 CN CN202411536275.7A patent/CN119709627A/zh not_active Withdrawn
- 2020-08-28 KR KR1020227043340A patent/KR20230004898A/ko active Pending
- 2020-08-28 EP EP20856951.7A patent/EP4022044A4/en not_active Withdrawn
- 2020-08-28 EP EP20856772.7A patent/EP4022041A4/en not_active Withdrawn
- 2020-08-28 MX MX2022002325A patent/MX2022002325A/es unknown
- 2020-08-28 KR KR1020227010201A patent/KR20220066291A/ko active Pending
- 2020-08-28 TW TW109129624A patent/TW202122574A/zh unknown
- 2020-08-28 AU AU2020336791A patent/AU2020336791A1/en not_active Abandoned
- 2020-08-28 CN CN202080073506.9A patent/CN114616323B/zh active Active
- 2020-08-28 US US17/639,249 patent/US20230085615A2/en not_active Abandoned
- 2020-08-28 CA CA3152936A patent/CA3152936A1/en active Pending
- 2020-08-28 TW TW109129629A patent/TW202122575A/zh unknown
- 2020-08-28 CA CA3150401A patent/CA3150401A1/en active Pending
- 2020-08-28 US US17/638,738 patent/US20220313738A1/en not_active Abandoned
- 2020-08-28 CN CN202080075654.4A patent/CN114599785A/zh active Pending
- 2020-08-28 AU AU2020339559A patent/AU2020339559A1/en not_active Withdrawn
-
2022
- 2022-02-18 ZA ZA2022/02127A patent/ZA202202127B/en unknown
- 2022-02-27 IL IL290946A patent/IL290946A/en unknown